Results 21 to 30 of about 125,484 (349)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors

Gastroenterology Research and Practice, 2015
In 2006, hypomagnesemia was first described as a complication of proton-pump inhibitors. To address this issue, we systematically reviewed the literature.
Simone Janett, Pietro Camozzi, Gabriëlla G. A. M. Peeters, Sebastiano A. G. Lava, Giacomo D. Simonetti, Barbara Goeggel Simonetti, Mario G. Bianchetti, Gregorio P. Milani   +7 more
doaj   +1 more source

Association of Histamine-2 Blockers and Proton-Pump Inhibitors With Delirium Development in Critically Ill Adults: A Retrospective Cohort Study

Critical Care Explorations, 2021
OBJECTIVES:. Histamine-2 receptor antagonists are commonly administered for stress ulcer prophylaxis in critically ill adults and may be associated with delirium development.
Ami Shiddapur, BS, Christine E. Kistler, MD, MASc, Jan Busby-Whitehead, MD, C. Adrian Austin, MD, MSCR   +3 more
doaj   +1 more source

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study [PDF]

, 2014
Objective: To examine the relation between the type of stress ulcer prophylaxis administered and the risk of postoperative pneumonia in patients undergoing coronary artery bypass grafting. Design: Retrospective cohort study.
Bateman, Brian T, Bykov, Katsiaryna, Choudhry, Niteesh K, Doherty, Michael, Fischer, Michael A, Franklin, Jessica M, Gagne, Joshua J, Polinski, Jennifer M, Rassen, Jeremy A, Schneeweiss, Sebastian   +9 more
core   +1 more source

ENDOSCOPIC AND HISTOPATHOLOGIC GASTRIC CHANGES IN CHRONIC USERS OF PROTON-PUMP INHIBITORS

Arquivos de Gastroenterologia, 2015
Background Proton-pump inhibitors have been used for at least two decades. They are among the most commonly sold drugs in the world. However, some controversy remains about the indications for their use and the consequences of their prolonged use ...
Sílvia Maria Perrone CAMILO, Élia Cláudia de Souza ALMEIDA, Benito André Silveira MIRANZI, Juliano Carvalho SILVA, Rosemary Simões NOMELINI, Renata Margarida ETCHEBEHERE   +5 more
doaj   +1 more source

Proton pump inhibitors and the risk of pneumonia: A comparison of cohort and self-controlled case series designs [PDF]

, 2013
Background: To compare the results of a new-user cohort study design and the self-controlled case series (SCCS) design using the risk of hospitalisation for pneumonia in those dispensed proton pump inhibitors compared to those unexposed as a case study ...
Australian Bureau of Statistics (ABS), C Farrington, C Farrington, C-S Eom, CP Farrington, DA Zink, Elizabeth E Roughead, Emmae N Ramsay, HJ Whitaker, HJ Whitaker, J Glanz, J Hippisley-Cox, KL Sloan, L Thomas, Nicole L Pratt, Philip Ryan, R Laheij, RJ Laheij, S Gulmez, S Suissa, S Suissa, SE Gulmez, SV Gadzhanova   +22 more
core   +1 more source

Proton Pump Inhibitors and Gastritis

Journal of Clinical Biochemistry and Nutrition, 2008
Proton pump inhibitors (PPIs) are novel compounds that strongly inhibit the H(+)/K(+)-ATPase in the gastric parietal cells to cause profound suppression of acid secretion. Acid-generating ATPase, also known as vacuolar-type ATPase, is located in the lysozomes of leukocytes and osteoclasts and its activity is also reportedly influenced by treatment with
Toshifumi Hibi, Masayuki Suzuki, Hidekazu Suzuki   +2 more
openaire   +4 more sources

Proton Pump Inhibitors and Clopidogrel [PDF]

Cardiovascular Therapeutics, 2010
Proton pump inhibitors are often prescribed for patients on clopidogrel to prevent gastrointestinal bleeding complications. Recent data suggest higher rates of adverse cardiovascular events in patients on proton pump inhibitors and clopidogrel, in comparison to patients on clopidogrel only.
Ron Waksman, Michael A. Gaglia
openaire   +2 more sources

Inappropriate use of proton pump inhibitors in non-critical indoor patients in a tertiary care teaching hospital in Eastern India [PDF]

, 2019
Background: Proton pump inhibitors are one of the most commonly used drugs worldwide. Often they are used for inappropriate indications too, imposing economic burden to patients and governments.
Dey, Shankar, Ghosh, Abhishek
core   +2 more sources

Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.

PLoS ONE, 2019
Stroke patients are at high risk of developing pneumonia, which is major cause of post-stroke mortality. Proton pump inhibitors and H2 receptor antagonists are anti-ulcer drugs, which may predispose to the development of pneumonia by suppression of the ...
Tae-Jin Song, Jinkwon Kim
doaj   +1 more source

Iron deficiency anemia from iron malabsorption caused by proton pump inhibitors

eJHaem, 2020
Background Iron deficiency anemia without evidence for blood loss can present a diagnostic challenge. Proton pump inhibitors have been associated with iron deficiency anemia for many years, yet the relationship between the two until recently was not ...
Michael Boxer
doaj   +1 more source